About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 10 record(s)
Req # A-2022-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th. So this request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well.Organization: Patented Medicine Prices Review Board Canada
December 2022
Req # A-2021-24949
Copies of all records related to the board meeting regarding the consultation results update on September 1, 2021 as referenced in Douglas Clark's calendar.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24950
Copies of all communication plans, strategies or similar documents prepared by PMPRB staff between May 1, 2021 and December 20, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-00001
Copies of all meeting minutes, presentations and speaking notes associated with the following 2018 meetings of the PMPRB Steering Committee on Modernization of Price Review Process Guidelines and the working group struck to inform that committee: July 26, August 15, August 22, August 24, September 12, September 25, October 12 and December 13.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10643
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Biosimilars Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10676
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PDCI Market Access over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10684
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and GlaxoSmithKline Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10689
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Janssen over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2020-18433
Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18442
A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.Organization: Patented Medicine Prices Review Board Canada
December 2020